IM
ImageneBio Inc (IMA)
NASDAQ·Healthcare·Biotechnology
$5.62
-1.58%
Mkt Cap $66.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
Implied Upside
-76.3%
Consensus $1.33 vs current $5.62
NASDAQ·Healthcare·Biotechnology
$5.62
-1.58%
Mkt Cap $66.20M
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
-76.3%
Consensus $1.33 vs current $5.62